{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:36:57Z","timestamp":1791196617315,"version":"4.1.0"},"reference-count":36,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.3892\/mmr.2012.959","type":"journal-article","created":{"date-parts":[[2012,6,20]],"date-time":"2012-06-20T07:45:40Z","timestamp":1340178340000},"page":"477-482","source":"Crossref","is-referenced-by-count":22,"title":["Parthenolide induces apoptosis and lytic cytotoxicity in Epstein-Barr virus-positive Burkitt lymphoma"],"prefix":"10.3892","volume":"6","author":[{"given":"YUAN","family":"LI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YONGLI","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MINGMING","family":"FU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QIN","family":"YAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HUIQIN","family":"ZHUO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QUANYI","family":"LU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIAOQING","family":"NIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PENG","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YIHUA","family":"PEI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KEJIE","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,6,20]]},"reference":[{"key":"key20180108014111_b1-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00008469-200508000-00004","article-title":"Statistics on cancer in China: cancer registration in 2002","volume":"14","author":"Yang","year":"2005","journal-title":"Eur J Cancer Prev"},{"key":"key20180108014111_b2-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int J Cancer"},{"key":"key20180108014111_b3-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","article-title":"Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8\u20139 September 2008","volume":"20","author":"Cohen","year":"2009","journal-title":"Ann Oncol"},{"key":"key20180108014111_b4-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein-Barr virus and the origins of associated lymphomas","volume":"350","author":"Thorley-Lawson","year":"2004","journal-title":"N Engl J Med"},{"key":"key20180108014111_b5-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nrmicro2015","article-title":"The curious case of the tumour virus: 50 years of Burkitt\u2019s lymphoma","volume":"6","author":"Thorley-Lawson","year":"2008","journal-title":"Nat Rev Microbiol"},{"issue":"Suppl 1","key":"key20180108014111_b6-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/10428190802311417","article-title":"Current understanding of the role of Epstein-Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas","volume":"49","author":"Cohen","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"key20180108014111_b7-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood-2006-01-024703","article-title":"A phase 1\/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies","volume":"109","author":"Perrine","year":"2007","journal-title":"Blood"},{"key":"key20180108014111_b8-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm.1864","article-title":"Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors","volume":"14","author":"Fu","year":"2008","journal-title":"Nat Med"},{"key":"key20180108014111_b9-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2003-03-0930","article-title":"Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1","volume":"103","author":"Landais","year":"2004","journal-title":"Blood"},{"key":"key20180108014111_b10-mmr-06-03-0477","first-page":"1920","article-title":"Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors","volume":"62","author":"Feng","year":"2002","journal-title":"Cancer Res"},{"key":"key20180108014111_b11-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"14596","DOI":"10.1073\/pnas.1105020108","article-title":"Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines","volume":"108","author":"Hailfinger","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108014111_b12-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11262-010-0505-4","article-title":"Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation","volume":"41","author":"Song","year":"2010","journal-title":"Virus Genes"},{"key":"key20180108014111_b13-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1073\/pnas.100119497","article-title":"NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells","volume":"97","author":"Cahir-McFarland","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108014111_b14-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1038\/sj.onc.1202976","article-title":"Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins","volume":"18","author":"Chaudhary","year":"1999","journal-title":"Oncogene"},{"key":"key20180108014111_b15-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"12592","DOI":"10.1073\/pnas.94.23.12592","article-title":"The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB","volume":"94","author":"Izumi","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108014111_b16-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1182\/blood.V96.7.2537","article-title":"Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells","volume":"96","author":"Keller","year":"2000","journal-title":"Blood"},{"key":"key20180108014111_b17-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-9255-2-6","article-title":"Comparative effects of the herbal constituent parthenolide (Feverfew) on lipopolysaccharide-induced inflammatory gene expression in murine spleen and liver","volume":"2","author":"Smolinski","year":"2005","journal-title":"J Inflamm (Lond)"},{"key":"key20180108014111_b18-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/0973-7847.79105","article-title":"Feverfew (Tanacetum parthenium L.): A systematic review","volume":"5","author":"Pareek","year":"2011","journal-title":"Pharmacogn Rev"},{"key":"key20180108014111_b19-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/annonc\/mdh232","article-title":"NF-kappa B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen","volume":"15","author":"deGraffenried","year":"2004","journal-title":"Ann Oncol"},{"key":"key20180108014111_b20-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1038\/sj.onc.1207995","article-title":"Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase","volume":"23","author":"Nakshatri","year":"2004","journal-title":"Oncogene"},{"key":"key20180108014111_b21-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2141.2010.08319.x","article-title":"The NF (Nuclear factor)-kappaB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7\/JNK1-dependent apoptosis in human acute myeloid leukaemia cells","volume":"151","author":"Dai","year":"2010","journal-title":"Br J Haematol"},{"key":"key20180108014111_b22-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1038\/sj.onc.1206548","article-title":"Virally targeted therapies for EBV-associated malignancies","volume":"22","author":"Israel","year":"2003","journal-title":"Oncogene"},{"key":"key20180108014111_b23-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1128\/JVI.75.10.4475-4481.2001","article-title":"Herpesvirus lytic replication and the cell cycle: arresting new developments","volume":"75","author":"Flemington","year":"2001","journal-title":"J Virol"},{"key":"key20180108014111_b24-mmr-06-03-0477","first-page":"67","article-title":"BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells","volume":"24","author":"Wang","year":"2004","journal-title":"Anticancer Res"},{"key":"key20180108014111_b25-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2174\/156801105774574649","article-title":"Inhibition of PI3K\/Akt signaling: an emerging paradigm for targeted cancer therapy","volume":"5","author":"Chen","year":"2005","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"key20180108014111_b26-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1158\/0008-5472.CAN-06-1006","article-title":"Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression","volume":"66","author":"Feng","year":"2006","journal-title":"Cancer Res"},{"key":"key20180108014111_b27-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/j.1460-2075.1989.tb03527.x","article-title":"The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites","volume":"8","author":"Urier","year":"1989","journal-title":"EMBO J"},{"key":"key20180108014111_b28-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1073\/pnas.93.17.9194","article-title":"Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism","volume":"93","author":"Zalani","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108014111_b29-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1128\/MMBR.65.1.131-150.2001","article-title":"Molecular pathways in virus-induced cytokine production","volume":"65","author":"Mogensen","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"key20180108014111_b30-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1172\/JCI11918","article-title":"Hostile takeovers: viral appropriation of the NF-kappaB pathway","volume":"107","author":"Hiscott","year":"2001","journal-title":"J Clin Invest"},{"key":"key20180108014111_b31-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/emboj\/cdg267","article-title":"NF-kappaB and virus infection: who controls whom","volume":"22","author":"Santoro","year":"2003","journal-title":"EMBO J"},{"key":"key20180108014111_b32-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1128\/JVI.77.15.8532-8540.2003","article-title":"NF-kappaB inhibits gammaherpesvirus lytic replication","volume":"77","author":"Brown","year":"2003","journal-title":"J Virol"},{"key":"key20180108014111_b33-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1074-5521(01)00049-7","article-title":"The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase","volume":"8","author":"Kwok","year":"2001","journal-title":"Chem Biol"},{"key":"key20180108014111_b34-mmr-06-03-0477","first-page":"1033","article-title":"Thermosensitization and induction of apoptosis or cell-cycle arrest human prostate cancer androgen-independent cell lines","volume":"28","author":"Hayashi","year":"2011","journal-title":"Int J Mol Med"},{"key":"key20180108014111_b35-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3109\/10428194.2011.555891","article-title":"The natural products parthenolide and andrographolide exhibit anti-cancer stem cell activity in multiple myeloma","volume":"52","author":"Gunn","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"key20180108014111_b36-mmr-06-03-0477","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000325204","article-title":"The NFkB pathway inhibitors Bay 11-7082 and parthenolide induce programmed cell death in anucleated Erythrocytes","volume":"27","author":"Ghashghaeinia","year":"2011","journal-title":"Cell Physiol Biochem"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2012.959\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T14:29:54Z","timestamp":1594304994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2012.959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,20]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,6,20]]},"published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.3892\/mmr.2012.959"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2012.959","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,20]]}}}